Pyridoxine 5'-phosphate oxidase (PNPO) (PNPO)

Pyridoxine 5'-phosphate oxidase (PNPO) is a rate-limiting enzyme in the vitamin B6 salvage pathway, responsible for the conversion of pyridoxine 5'-phosphate (PNP) and pyridoxamine 5'-phosphate (PMP) into the biologically active cofactor pyridoxal 5'-phosphate (PLP) [3, 4, 6]. As an FMN-dependent oxidoreductase, it plays an essential role in maintaining the cellular pool of PLP, which is required for the activity of over 140 distinct enzymes involved in amino acid metabolism and the biosynthesis of vital neurotransmitters like GABA, serotonin, and dopamine [17, 18, 20]. Mutations in the PNPO gene result in PNPO deficiency, a rare autosomal recessive metabolic disorder that presents as neonatal epileptic encephalopathy, typically characterized by intractable seizures that respond to PLP rather than standard anticonvulsants [11, 21]. Beyond inherited deficiencies, PNPO activity and B6 homeostasis are frequently compromised by drugs such as isoniazid, cycloserine, and penicillamine, which act as B6 antagonists and can induce peripheral neuropathy [1, 13, 16]. Recent studies also suggest a regulatory role for PNPO in certain cancers and neuropsychiatric conditions, highlighting its broader systemic importance [12, 19]. Clinical management requires vigilant monitoring of PLP levels and potential safety concerns such as sensory neuropathy from excess B6 or liver toxicity associated with high-dose replacement therapy [10, 15, 22].

Other names

Pyridoxamine-phosphate oxidasePyridoxine-5'-phosphate oxidasePMP oxidasePNP oxidasePyridoxamine 5'-phosphate oxidasePyridoxal 5'-phosphate synthase

Catalyzes the FMN-dependent oxidation of pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP) using molecular oxygen as an electron acceptor.